FX & CFD trading involves significant risk
Johnson & Johnson (JNJ) earned $1.56 per share in the first quarter, beating analysts' estimate of $1.54. Revenue in the first quarter decreased by 4.1% year-over-year to $17.37 billion, but beating analysts' estimate of $17.33 billion.
The company reported that domestic sales increased 5.9%, while international sales fell 12.4%.
The company lowered its forecasts for 2015 to $6.04-$6.19 per share (analysts' estimate: $6.18 per share) from the previous estimate of $6.12-$6.27 per share.
Johnson & Johnson (JNJ) shares increased to $101.01 (+0.46%) prior to the opening bell.
All posted material is a marketing communication solely for informational purposes and reliance on this may lead to loss. Past performance is not a reliable indicator of future results. Please read our full disclaimer.